Common Contracts
1 similar null contracts
EXPANDED LICENSING AGREEMENT FOR TYVYT® (SINTILIMAB INJECTION) WITH LILLYApril 13th, 2019
This announcement is made by Innovent Biologics, Inc. (the “Company”, together with its subsidiaries, the “Group”) pursuant to Rule 13.09(2)(a) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”) and the inside information provision (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong).
